Literature DB >> 23485810

Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways.

M P Cunha1, M D Martín-de-Saavedra, A Romero, E Parada, J Egea, L Del Barrio, A L S Rodrigues, M G López.   

Abstract

The guanidine-like compound creatine exerts bioenergetic, antiexcitotoxic, antioxidant and neuroprotective properties; however, the intracellular mechanisms responsible for these effects are still not well established. The purpose of this study was to investigate the protective effect of creatine against 6-hydroxydopamine (6-OHDA)-induced cell death in neuroblastoma SH-SY5Y cells and the possible intracellular signaling pathways involved in such effect. Exposure of SH-SY5Y cells to 100-300μM of 6-OHDA for 24h caused a significant concentration-dependent cell death measured as a diminution of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) reduction and as an increase in the extracellular release of lactate dehydrogenase. SH-SY5Y cells incubated for 24 or 48h with creatine (10-5000μM) was not cytotoxic. However, pre and co-treatment with creatine (0.3-1000μM) for 24h reduced 6-OHDA-induced toxicity. The protective effect afforded by creatine against 6-OHDA-induced toxicity was reversed by inhibitors of different protein kinases, i.e. phosphatidylinositol-3 kinase (PI3K) (LY294002), Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) (KN-93), protein kinase A (H-89), mitogen-activated protein kinase kinase 1/2 (MEK1/2) (PD98059) and protein kinase C (PKC) (chelerythrine). Furthermore, creatine prevented the 6-OHDA-induced dephosphorylation of glycogen synthase kinase-3β (GSK-3β) at the serine 9 residue. In conclusion, the results of this study show that creatine can protect against 6-OHDA-induced toxicity and its protective mechanism is related to a signaling pathway that involves PI3K, PKC, PKA, CaMKII, MEK1/2 and GSK-3β.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23485810     DOI: 10.1016/j.neuroscience.2013.02.030

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Creatine Protects Against Cytosolic Calcium Dysregulation, Mitochondrial Depolarization and Increase of Reactive Oxygen Species Production in Rotenone-Induced Cell Death of Cerebellar Granule Neurons.

Authors:  Sofia Fortalezas; Dorinda Marques-da-Silva; Carlos Gutierrez-Merino
Journal:  Neurotox Res       Date:  2018-08-09       Impact factor: 3.911

2.  Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine.

Authors:  Mauricio P Cunha; Josiane Budni; Fabiana K Ludka; Francis L Pazini; Julia Macedo Rosa; Ágatha Oliveira; Mark W Lopes; Carla I Tasca; Rodrigo B Leal; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2015-05-06       Impact factor: 5.590

3.  Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®).

Authors:  Alejandro Romero; Esther Parada; Laura González-Lafuente; Victor Farré-Alins; Eva Ramos; Ramón Cacabelos; Javier Egea
Journal:  CNS Neurosci Ther       Date:  2017-03-30       Impact factor: 5.243

4.  Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.

Authors:  Francis L Pazini; Mauricio P Cunha; Julia M Rosa; André R S Colla; Vicente Lieberknecht; Ágatha Oliveira; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.590

5.  Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.

Authors:  Zuhair I Abdulla; Bahar Pahlevani; Kerstin H Lundgren; Jordan L Pennington; Kenea C Udobi; Kim B Seroogy; Matthew R Skelton
Journal:  J Mol Neurosci       Date:  2019-09-13       Impact factor: 3.444

6.  Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.

Authors:  Mauricio Peña Cunha; Maria D Martín-de-Saavedra; Alejandro Romero; Javier Egea; Fabiana K Ludka; Carla I Tasca; Marcelo Farina; Ana Lúcia S Rodrigues; Manuela G López
Journal:  ASN Neuro       Date:  2014-11-24       Impact factor: 4.146

7.  P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells.

Authors:  Xiang-Bao Meng; Gui-Bo Sun; Min Wang; Jing Sun; Meng Qin; Xiao-Bo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-18       Impact factor: 2.629

8.  Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating Injury.

Authors:  Kelly A Chamberlain; Kristen S Chapey; Sonia E Nanescu; Jeffrey K Huang
Journal:  J Neurosci       Date:  2017-01-09       Impact factor: 6.167

9.  Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model.

Authors:  Joana Silva; Celso Alves; Susete Pinteus; Susana Mendes; Rui Pedrosa
Journal:  BMC Complement Altern Med       Date:  2018-02-14       Impact factor: 3.659

10.  Anacardium microcarpum Promotes Neuroprotection Dependently of AKT and ERK Phosphorylation but Does Not Prevent Mitochondrial Damage by 6-OHDA.

Authors:  Illana Kemmerich Martins; Nélson Rodrigues de Carvalho; Giulianna Echeverria Macedo; Nathane Rosa Rodrigues; Cynthia Camila Ziech; Lúcia Vinadé; Valter Menezes Barbosa Filho; Irwin Alencar Menezes; Jeferson Franco; Thaís Posser
Journal:  Oxid Med Cell Longev       Date:  2018-10-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.